ClinicalTrials.Veeva

Menu

Genetic Causes of Familial Hypercholesterolemia

R

Region Örebro County

Status

Active, not recruiting

Conditions

Familial Hypercholesterolemia

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Familial hypercholesterolemia (FH) is a common disease. The genetic background to FH is not yet fully understood. In the present prospective cohort study we aim to study the association between different clinical characteristics, gene mutations and prognosis.

Full description

In this prospective observational cohort study of patients with high clinical suspicion of familial hypercholesterolemia (FH) we aim to study the association between different clinical characteristics, gene mutations and prognosis.

The included patients will undergo physical examination and extended blood sampling. DNA will be extracted and used for both whole genome sequencing and investigation of both known- , unknown- and suspected mutations associated with FH.

The patients will be followed in for 15 years in the Swedish patients registry and the Swedish cause of death registry.

Enrollment

150 estimated patients

Sex

All

Ages

8+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age 8 years or older.
  2. Clinical suspicion of FH
  3. Dutch Lipid Clinic Network Score of at least four or a first grade relative with a genetic deviation that may be associated with FH.

Exclusion criteria

  1. Age below 8 years.

Trial design

150 participants in 1 patient group

Group 1
Description:
Patients with high clinical suspicion of familial hypercholesterolemia. No intervention.
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Anna M Nordenskjöld, MD, PhD; Anna Green, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems